Want to see TRDA full AI Analyst Report?
Entrada Therapeutics Inc (TRDA) Ownership Overview
34.73% Insiders
8.13% Mutual Funds
40.50% Other Institutional Investors
8.93% ETFs
7.71% Public Companies and
Individual Investors
The ownership structure of Entrada Therapeutics Inc (TRDA) stock is a mix of institutional, retail, and individual investors. Approximately 57.56% of the company’s stock is owned by Institutional Investors, 34.73% is owned by Insiders, and 7.71% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Aug 26, 2026 | xxxxxxxxxxxxx | $461546 | |
Aug 26, 2026 | xxxxxxxxxxxxx | $461546 | |
Aug 10, 2026 | xxxxxxxxxxxxx | $1078937 | |
Aug 10, 2026 | xxxxxxxxxxxxx | $431829 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Jun 30, 2026 | xxxxxxxxxxxxx | $610159 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $1071616 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $246244 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,072,730 | Institution | 13.03% | 35,509,110 | |
| 4,691,392 | Insider | 12.05% | 32,839,744 | |
| 4,318,348 | Insider | 11.09% | 30,228,436 | |
| 4,318,348 | Insider | 11.09% | 30,228,436 | |
| 3,877,094 | Insider | 9.96% | 27,139,658 | |
| 3,784,650 | Insider | 9.72% | 26,492,550 | |
| 1,489,292 | Institution | 3.82% | 10,425,044 | |
| 1,353,881 | Institution | 3.48% | 9,477,167 | |
| 1,226,870 | Institution | 3.15% | 8,588,090 | |
| 526,014 | Insider | 1.35% | 3,682,098 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,226,870 | Institution | 3.15% | 8,588,090 | |
| 329,233 | Institution | 0.85% | 2,304,631 | |
| 318,563 | Institution | 0.82% | 2,229,941 | |
| 243,881 | Institution | 0.63% | 1,707,167 | |
| 164,005 | Institution | 0.42% | 1,148,035 | |
| 129,823 | Institution | 0.33% | 908,761 | |
| 122,777 | Institution | 0.32% | 859,439 | |
| 81,949 | Institution | 0.21% | 573,643 | |
| 76,461 | Institution | 0.20% | 535,227 | |
| 70,280 | Institution | 0.18% | 491,960 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 953,727 | Institution | 2.45% | 6,475,806 | |
| 758,020 | Institution | 1.95% | 5,306,140 | |
| 283,038 | Institution | 0.73% | 1,921,828 | |
| 268,756 | Institution | 0.69% | 1,881,292 | |
| 166,122 | Institution | 0.43% | 1,127,968 | |
| 158,464 | Institution | 0.41% | 1,109,248 | |
| 112,495 | Institution | 0.29% | 857,212 | |
| 102,278 | Institution | 0.26% | 715,946 | |
| 70,054 | Institution | 0.18% | 533,811 | |
| 67,775 | Institution | 0.17% | 516,446 |
FAQ
Who Owns Entrada Therapeutics Inc (TRDA)?
According to the latest TipRanks data, approximately 40.50% of the company's stock is held by institutional investors, 34.73% is held by insiders, and 7.71% is held by retail investors.
What percentage of Entrada Therapeutics Inc (TRDA) stock is held by institutional investors?
According to the latest TipRanks data, approximately 40.50% of Entrada Therapeutics Inc (TRDA) stock is held by institutional investors.
What percentage of Entrada Therapeutics Inc (TRDA) stock is held by retail investors?
According to the latest TipRanks data, approximately 7.71% of Entrada Therapeutics Inc (TRDA) stock is held by retail investors.
Who owns the most shares of Entrada Therapeutics Inc (TRDA)?
Felix Baker owns the most shares of Entrada Therapeutics Inc (TRDA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.